Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study
Author:
Funder
Daiichi-Sankyo
Merck
Medizinische Universität Wien
Roche
Amgen
Bristol-Myers Squibb
AbbVie
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference43 articles.
1. Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: a systematic review and meta-analysis;Tagliamento;Crit Rev Oncol Hematol,2021
2. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study;Pinato;Lancet Oncol,2021
3. Time-dependent COVID-19 mortality in patients with cancer;Pinato;JAMA Oncol,2022
4. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study;Kuderer;Lancet,2020
5. SARS-CoV-2 vaccines for cancer patients: a call to action;Corti;Eur J Cancer,2021
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment;Journal of Functional Biomaterials;2024-08-16
2. Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects;Frontiers in Immunology;2024-01-26
3. Efficacy of COVID-19 Vaccines in Patients with Hematological Malignancy Compared to Healthy Controls: A Systematic Review and Meta-analysis;JMA Journal;2024
4. Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort;ESMO Open;2023-06
5. The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases;Pharmacology & Therapeutics;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3